electroCore Inc

ECOR

Company Profile

  • Business description

    electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

  • Contact

    200 Forge Way
    Suite 205
    RockawayNJ07866
    USA

    T: +1 973 290-0097

    E: [email protected]

    https://www.electrocore.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    62

Stocks News & Analysis

stocks

Ask the analyst: How reliant are Guzman shares on international growth?

A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.
stocks

Nvidia: Back in business in China; Raising fair value estimate

Nvidia is poised to become more dominant than ever as it is allowed to sell its key H20 GPUs in China.
stocks

Our top ASX picks in every sector

These companies are our top choices for investors wanting to boost Aussie exposure.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,816.4058.90-0.66%
CAC 407,768.111.900.02%
DAX 4024,091.2530.960.13%
Dow JONES (US)44,023.29436.36-0.98%
FTSE 1008,954.5616.240.18%
HKSE24,517.7672.36-0.29%
NASDAQ20,677.8037.470.18%
Nikkei 22539,663.4014.62-0.04%
NZX 50 Index12,754.5964.960.51%
S&P 5006,243.7624.80-0.40%
S&P/ASX 2008,561.8068.50-0.79%
SSE Composite Index3,503.781.22-0.03%

Market Movers